Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting (Q39978620)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting |
scientific article |
Statements
1 reference
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting (English)
1 reference
1 reference
Francesco Montorsi
1 reference
Giorgio Guazzoni
1 reference
Luciano Nava
1 reference
Vincenzo Scattoni
1 reference
Giovanni Lughezzani
1 reference
Carmen Maccagnano
1 reference
Fernanda Dorigatti
1 reference
Ferruccio Ceriotti
1 reference
Marina Pontillo
1 reference
Vittorio Bini
1 reference
Massimo Freschi
1 reference
Patrizio Rigatti
1 reference
5 April 2011
1 reference
1 reference
Identifiers
1 reference